PreTrain NRG
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80077347
- Status
- Active licence
- Licence date
- 10 May 2017
- Revision date
- 16 January 2023
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Chélate de créatine magnésium | 200 milligramme | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : N-acétyl L-chlorhydrate de carnitine | 1.5 Grammes | Not calculated |
| N-méthyl-N-guanylglycine Source : Chélate de créatine magnésium | 1.1 Grammes | Not calculated |
| 2-acétylamino-3-(4-hydroxyphényl)-acide propanoïque Source : N-acétyltyrosine | 750 milligramme | Not calculated |
| Adénosine 5'-(tétrahydrogène triphosphate), sel de disodium Source : Adénosine triphosphate disodium | 400 milligramme | Not calculated |
| L-théanine Source : L-Théanine | 200 milligramme | Not calculated |
| 1,3,7-triméthylxanthine Source : Coffea canephora - Graine | 100 milligramme | Not calculated |
Non-medicinal ingredients
Saveur, Acide citrique, Stevia leaf
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Portion(s) | 1 Tous les jours |
Uses authorised in Canada
Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Helps to support cognitive health and/or brain function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you have liver disease, kidney disease and/or a seizure disorder, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. May result in weight gain.
- Effets indésirables connus
May cause digestive problems. Hypersensitivity/allergy is known to occur, in which case, discontinue use.
Source
Official Health Canada record, licence 80077347
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging